A French start-up has urged the development of more powerful drugs to combat antibiotic-resistant diseases, with its new drug, Eligobiotics.
UK scientists have edited the DNA of human embryos for the first time, helping them further understand infertility and miscarriage.
Craig Venter’s start-up, Human Longevity hasn’t fulfilled its promises as it faces backlash from critics.
New method allows ‘20,000 parallel experiments’ in search for gene activators
There may be some doubt about the conclusions of the ground-breaking paper on human germline engineering in the USA
What did the recent study using the CRISPR gene editing technique actually entail, and what did we learn from it?
CRISPR could be the tool that brings the importance of sickle-cell to the forefront, a disease that has long been under served by the medical industry.
CRISPR Therapeutics’ collaboration with Massachusetts General Hospital expands its efforts in immuno-oncology.